“Decisive And Rapid” Action Needed On UK Regulations As Target Dates Looking Unlikely

The UK is in political and economic turmoil. There has been an exodus of staff at the UK’s medtech regulatory agency, the MHRA. And now it is looking as if the supposed post-Brexit opportunities to legislate medtech creatively may be lost. 

Compass
Has The UK Lost Its Regulatory Compass? • Source: Alamy

“Urgent action on completing the necessary legislative processes” for the regulation of medtech products is needed in the UK, Peter Ellingworth, chief executive of the Association of British HealthTech Industries (ABHI), has said.

In a letter printed in the UK’s Financial Times on 13 October on the morning of the first in-person ABHI...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Europe

More from Geography